Eledon Pharmaceuticals (2TK) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tacrolimus, At-1501 | Kidney Transplant Rejection | Phase II | Enrolling By Invitation | Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients | Nov 06, 2023 | ― |
| Tacrolimus, At-1501 | Kidney Transplant Rejection | Phase II | Active Not Recruiting | Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation | Aug 02, 2023 | ― |
| At-1501 | Prevention Of Rejection In Kidney Transplant | phase1AndPhase2 | Recruiting | Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant | Aug 19, 2021 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Tacrolimus, At-1501 | Phase II | Kidney Transplant Rejection | Enrolling By Invitation | Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients | Nov 06, 2023 | ― |
| Tacrolimus, At-1501 | Phase II | Kidney Transplant Rejection | Active Not Recruiting | Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation | Aug 02, 2023 | ― |
| At-1501 | phase1AndPhase2 | Prevention Of Rejection In Kidney Transplant | Recruiting | Safety, Pharmacokinetics, and Efficacy of AT 1501 in Patients Undergoing Kidney Transplant | Aug 19, 2021 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eledon Pharmaceuticals, Inc. (DE:2TK) have in its pipeline
Eledon Pharmaceuticals DE:2TK is currently developing the following drugs: Tacrolimus, At-1501, At-1501. These drug candidates are in various stages of clinical development as the company works toward FDA approval.